NAMSA expands medical device testing services

Share

NAMSA (Toledo, Ohio) recently announced that it has launched its Analytical Services Laboratory in Obernburg, Germany to further expand access to accelerated product development and testing services.

The company’s new facility offers European device manufacturers a facility that meets ISO 10993-18 testing requirements. It will also offer exhaustive extraction, FTIR, GC-MS, LC-MS and ICP-MS services in that region.

“NAMSA is excited to add to its global portfolio of services with the introduction of its new Obernberg laboratory,” Ulrich Gohlke, director of German lab operations, said in a press release. “NAMSA is proud of its strong working relationships with EU regulatory entities, including the European Commission, and demonstrated track record of delivering significant time and cost savings throughout the medical device development continuum. With the introduction of NAMSA’s new Analytical Services Laboratory, we look forward to providing European device makers significant development efficiencies, including closer collaboration through an ideally-located testing partner.”

NAMSA’s Analytical Services Laboratory will have its grand opening on March 6. The company will offer laboratory tours, complimentary consultations, scientific sessions, keynote addresses and a networking reception at the lab’s launch.

Last Chance to Save for DeviceTalks Boston!

textadimage Early rates for DeviceTalks Boston end August 15th.

Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.

View Full Agenda

Register today to save. Use code LASTCALL to save an additional 10%.

Speak Your Mind

*